Moderately bullish activity in Novo Nordisk (NVO), with shares up $3.27, or 7.19%, near $48.65. Options volume running well above average with 168k contracts traded and calls leading puts for a put/call ratio of 0.44, compared to a typical level near 0.8. Implied volatility (IV30) is higher by 0.0 points near 41.45,and below the 52wk median, suggesting an expected daily move of $1.27. Put-call skew steepened, indicating increased demand for downside protection, following a downgrade to Neutral at UBS.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Video: Why Eli Lilly Is Underperforming Today
- BofA defends Eli Lilly following selloff on weight loss pill trial data
- Eli Lilly stock move ‘way overdone,’ says BofA
- Leerink downgrades Eli Lilly with thesis changed after results for orforglipron
- Novo’s Wegovy, Eli’s Mounjaro sales for July double in India, Reuters says